Charles M. Perou
Gründer bei GeneCentric Therapeutics, Inc.
Profil
Charles M.
Perou is the founder of GeneCentric Therapeutics, Inc. which was founded in 2011.
He is currently a Member at The University of North Carolina at Charlotte since 2000.
Dr. Perou holds a doctorate degree from the University of Utah and an undergraduate degree from Bates College.
Aktive Positionen von Charles M. Perou
Unternehmen | Position | Beginn |
---|---|---|
GeneCentric Therapeutics, Inc.
GeneCentric Therapeutics, Inc. Medical SpecialtiesHealth Technology GeneCentric Therapeutics, Inc. develops and commercializes molecular diagnostic assays. Its product enables oncologists and patients to make more informed, individualized treatment decisions. The firm's product CSP identifies cancer subtypes that enable drug developers to meet the growing demand for precision medicines, and provide clinicians the information they need to make individualized treatment decisions. The company was founded by David Neil Hayes, Charles M. Perou, and Myla P. Lai-Goldman in 2011 and is headquartered in Durham, NC. | Gründer | 01.01.2011 |
The University of North Carolina at Charlotte | Corporate Officer/Principal | 01.01.2000 |
Ausbildung von Charles M. Perou
Bates College | Undergraduate Degree |
University of Utah | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
GeneCentric Therapeutics, Inc.
GeneCentric Therapeutics, Inc. Medical SpecialtiesHealth Technology GeneCentric Therapeutics, Inc. develops and commercializes molecular diagnostic assays. Its product enables oncologists and patients to make more informed, individualized treatment decisions. The firm's product CSP identifies cancer subtypes that enable drug developers to meet the growing demand for precision medicines, and provide clinicians the information they need to make individualized treatment decisions. The company was founded by David Neil Hayes, Charles M. Perou, and Myla P. Lai-Goldman in 2011 and is headquartered in Durham, NC. | Health Technology |